View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

EQS-News: Just – Evotec Biologics eröffnet hochmoderne Biologika-Anlag...

EQS-News: Evotec SE / Schlagwort(e): Sonstiges Just – Evotec Biologics eröffnet hochmoderne Biologika-Anlage - J.POD® Toulouse, France (EU) 20.09.2024 / 15:29 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.   J.POD® Toulouse, France (EU) bringt disruptive, skalierbare, kontinuierliche Biologika-Herstellungstechnologie in die Region Just – Evotec Biologics J.POD®-Technologie bietet einen Paradigmenwechsel in der Bioproduktion mit kosteneffizienten und flexiblen Lösungen für die klinische und kommerzielle Versorgung   ...

 PRESS RELEASE

EQS-News: Just – Evotec Biologics opens cutting-edge biologics facilit...

EQS-News: Evotec SE / Key word(s): Miscellaneous Just – Evotec Biologics opens cutting-edge biologics facility - J.POD® Toulouse, France (EU) 20.09.2024 / 15:29 CET/CEST The issuer is solely responsible for the content of this announcement.   J.POD® Toulouse, France (EU) brings disruptive, scalable continuous biologics manufacturing technology to the region Just – Evotec Biologics’ J.POD® technology offers a paradigm shift in biomanufacturing with cost-effective and flexible clinical and commercial supply solutions   Hamburg, Germany, and Toulouse, Franc...

Evotec SE: 1 director

A director at Evotec SE bought 10,000 shares at 6.109EUR and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

 PRESS RELEASE

EQS-News: Therese Jandér übernimmt die Leitung Investor Relations bei ...

EQS-News: Wienerberger AG / Schlagwort(e): Personalie Therese Jandér übernimmt die Leitung Investor Relations bei wienerberger 12.09.2024 / 08:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Therese Jandér übernimmt die Leitung Investor Relations bei wienerberger   Wien, 12. September 2024 – Mit 1. September hat Therese Jandér (47) als Senior Vice President Investor Relations die Leitung der IR-Abteilung der Wienerberger AG übernommen. In ihrer neuen Funktion verantwortet sie die Finanzmarktkommunikation von wienerberger, dem fü...

 PRESS RELEASE

EQS-News: Therese Jandér joins wienerberger as Senior Vice President o...

EQS-News: Wienerberger AG / Key word(s): Personnel Therese Jandér joins wienerberger as Senior Vice President of Investor Relations 12.09.2024 / 08:00 CET/CEST The issuer is solely responsible for the content of this announcement. Therese Jandér joins wienerberger as Senior Vice President of Investor Relations   Vienna, September 12, 2024 – On September 1, Therese Jandér (47) took over the management of the IR department of Wienerberger AG as Senior Vice President of Investor Relations. In her new role, she is responsible for the financial market communication of wiene...

Glanbia: 1 director

A director at Glanbia bought 5,070 shares at 16.078EUR and the significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...

Oliver Metzger ... (+2)
  • Oliver Metzger
  • Sinan Doganli

ODDO : First feedback – DAY 2

We host the 15th edition of the Corporate Conference in cooperation with Commerzbank on September 3rd & 4th 2024 in Frankfurt am Main. This year we are welcoming 90 German small, mid and large cap companies. - >Accelor Mittal (=) – Heading for better H2 despite still soft underlying markets, no change on VallourecAdesso (=) – IT-solutions segment will continue to be a drag on profitability in H2 2024Aurubis (+) – Announced disposal for its US-based finished ...

Oliver Metzger ... (+2)
  • Oliver Metzger
  • Sinan Doganli

ODDO : First feedback – DAY 1

We host the 15th edition of the Corporate Conference in cooperation with Commerzbank on September 3rd & 4th 2024 in Frankfurt am Main. This year we are welcoming 90 German small, mid and large cap companies. - >Adidas (+) – On trackAixtron (=) – No short-term inflection, but high confidence in long-term prospectsAllgeier (+) – Is confident it can achieve 15% EBITDA margin by the end of 2025 ams OSRAM (=) – Some cautiousness on auto/industrial, still co...

 PRESS RELEASE

EQS-News: Evotec gibt Veränderung im Vorstand bekannt

EQS-News: Evotec SE / Schlagwort(e): Sonstiges Evotec gibt Veränderung im Vorstand bekannt 03.09.2024 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.   Dr. Matthias Evers tritt mit Wirkung zum 01. Oktober 2024 als Chief Business Officer zurück Verantwortlichkeiten werden auf andere Vorstandsressorts verteilt   Hamburg, 03. September 2024: Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) gab heute bekannt, dass ihr Chief Business Officer, Dr. Matthias Evers entschieden...

 PRESS RELEASE

EQS-News: Evotec announces change in Management Board

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec announces change in Management Board 03.09.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement.   Dr Matthias Evers steps down as Chief Business Officer effective 01 October 2024 Distribution of responsibilities across other Management Board functions   Hamburg, Germany, 03 September 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that its Chief Business Officer, Dr Matthias Evers, has decided to s...

 PRESS RELEASE

EQS-News: Novem Group S.A.: Hauptversammlung stimmt allen Tagesordnung...

EQS-News: Novem Group S.A. / Schlagwort(e): Hauptversammlung Novem Group S.A.: Hauptversammlung stimmt allen Tagesordnungspunkten zu 22.08.2024 / 16:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Novem Group S.A.: Hauptversammlung stimmt allen Tagesordnungspunkten zu Luxemburg, 22. August 2024 – Die Aktionärinnen und Aktionäre der Novem Group S.A. haben heute auf der Hauptversammlung allen Tagesordnungspunkten mit großer Mehrheit zugestimmt. Insgesamt waren auf der Hauptversammlung 92,4% des stimmberechtigten Grundkapitals vertre...

 PRESS RELEASE

EQS-News: Novem Group S.A.: Annual General Meeting approves all items ...

EQS-News: Novem Group S.A. / Key word(s): AGM/EGM Novem Group S.A.: Annual General Meeting approves all items on the agenda 22.08.2024 / 16:30 CET/CEST The issuer is solely responsible for the content of this announcement. Novem Group S.A.: Annual General Meeting approves all items on the agenda Luxembourg, 22 August 2024 – The shareholders of Novem Group S.A. approved all agenda items at today’s Annual General Meeting (AGM) by a large majority. In total, 92.4% of the voting share capital was represented at the AGM. In accordance with the proposal of the Management Boar...

Carole Braudeau
  • Carole Braudeau

Credit Morning 08/20/2024

Voltalia : curtailment on electricity in Brazil>...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 20/08/2024

Voltalia : Ecrêtement du flux d’électricité au Brésil>...

Fatma Agnès Hamdani
  • Fatma Agnès Hamdani

Glanbia : Continued momentum on the emblematic ON brand. Whey prices s...

>SlimFast and difficulties in in speciality channel weigh on GPN's H1 sales - The 0.8% fall in GPN sales was underpinned by 3.3% growth in the international zone, while the Americas region was down 3%. Despite a high base effect, the ON brand remained very dynamic (+7.7%, of which 11.8% in volume), supported by marketing investments. The brand gained market share and new points of sale. SlimFast (7% of sales) continues to weigh on sales (-34%), as do the difficulties ...

Chaima Ferrandon ... (+2)
  • Chaima Ferrandon
  • Sven Edelfelt

Wienerberger : Still a tricky year in 2024 but the worst seems to be o...

>Q2 EBITDA in line with forecasts and decline in full-year guidance - Wienerberger reported Q2 2024 sales up at € 1,292m (volumes -2%, scope +14%, prices -3%) and underlying EBITDA of € 285m, up 16% in line with our forecasts. The upturn in EBITDA is driven by the integration of Terreal and self-help (€ 12M in Q2) and strong cost management (€ 15m), helping to offset the decline in volumes (-€ 7m) and a negative price-cost ratio (-€ 24m). The margin improved by +72bp...

Klaus Ringel ... (+2)
  • Klaus Ringel
  • Michael Foundoukidis

Novem : A weak start to FY-24/25 and persistent muted prospects

>A soft start in Q1-24/25 as expected - Novem’s Q1-24/25 reported Group sales are -20% YOY to € 140m (in-line with ODDO BHF) in a weak market environment with lackluster demand in the automotive sector with Europe standing out. Revenues in Series are -21% YOY to € 120m in Q2-24, suffering from an overall weak customer demand and volatile call-offs. Sales in Tooling are -16% YOY to € 20m in the quarter under review. Regionally, the sales decline is driven by Europe (-4...

Fehmi Ben Naamane
  • Fehmi Ben Naamane

TUI AG : No deceleration of demand; full-year guidance looks very cred...

>Brisk business in Q3 - TUI AG's Q3 2024 results publication was of a very high quality and provided reassurance about demand trends in a tougher global environment. The figures came in 3% and 9% above our estimates for revenues and adjusted EBIT respectively. The main difference compared with our expectations was due to brisker business in the hotels division (and better-than-expected price growth of +7%) and, to a lesser extent, in the markets & airlines division. T...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch